Related Experiment Video
Updated: Jun 3, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Treatment options for hypertension in high-risk patients
1Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan. wctsai@ksmail.seed.net.tw
Insights
High-risk patients with conditions like diabetes or stroke benefit significantly from blood pressure-lowering therapy to reduce cardiovascular events. Angiotensin-converting enzyme inhibitors or receptor antagonists are recommended treatments for hypertension in these individuals.
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
Background:
- Cardiovascular events pose a significant risk for patients with diabetes, chronic kidney disease, stroke, or coronary artery disease.
- Hypertension management is crucial for mitigating cardiovascular risk in high-risk populations.
- Global risk evaluation is recommended for all hypertensive patients to identify those at high risk.
Purpose of the Study:
- To summarize the cardiovascular risk factors and recommended treatment strategies for hypertensive patients.
- To highlight the efficacy of blood pressure-lowering therapies in high-risk individuals.
Main Methods:
- Review of clinical trials and guidelines concerning hypertension management in high-risk patients.
- Identification of key risk factors for cardiovascular events.
Main Results:
- Patients with diabetes, chronic kidney disease, stroke, or coronary artery disease are considered high-risk for cardiovascular events.
- Blood pressure-lowering therapy significantly reduces cardiovascular events in these high-risk patients.
- Angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists, potentially with dihydropyridine calcium channel antagonists, are effective treatment options.
Conclusions:
- Early identification and aggressive management of hypertension are vital for high-risk patients.
- Pharmacological interventions targeting blood pressure are essential for preventing cardiovascular events in this population.
Abstract:
Patients are considered to be at high risk of cardiovascular events if they have diabetes, chronic kidney disease, stroke, established coronary artery disease, or a coronary artery disease equivalent. Blood pressure-lowering therapy has been shown to reduce cardiovascular events in these patients significantly. Identification of high-risk patients by global risk evaluation is recommended for every hypertensive patient. Treatment of hypertension in high-risk patients with an angiotensin-converting enzyme inhibitor or an angiotensin receptor antagonist, with or without addition of a dihydropyridine calcium channel antagonist, is a reasonable approach based on current clinical trials.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
Heart Failure V: Medical Management
Hypertension I: Introduction